George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorman Broadb Regulatory News (NBB)

Share Price Information for Norman Broadb (NBB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 8.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 1.50 (17.647%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
NBB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

14 Nov 2022 07:00

RNS Number : 2058G
Norman Broadbent PLC
14 November 2022
 

14 November 2022

 

Norman Broadbent plc

(the "Company")

 

Issue of Equity,

 Director/PDMR shareholding

and

Total Voting Rights

 

Norman Broadbent plc (AIM: NBB), a leading quoted Executive Search and Interim Management firm offering a diversified portfolio of integrated Leadership Acquisition & Advisory Services, announces that it has issued 1,076,753 new ordinary shares of 1p each ("New Shares") at 3.75 pence per New Share to an executive director of the Company ("Director"), certain Persons Discharging Managerial Responsibilities ("PDMRs") and certain employees in lieu of part of their annual cash bonus.

 

Application has been made to the London Stock Exchange for the New Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission and dealings in the New Shares will occur at 8.00 a.m. on 18 November 2022. The New Shares will be issued credited as fully paid and rank in full for all dividends and other distributions declared, made or paid after Admission and will otherwise be identical to and rank pari passu in all respects with the existing ordinary shares of 1p each in the capital of the Company ("Ordinary Shares"). 

 

Director/PDMR shareholding

As set out above, a Director, certain PDMRs and certain employees have been issued New Shares, details of which are set out below:

 

 

 

 

 

 

 

 

Name

 

 

 

 

 

 

Position held

 

 

Number of New Shares issued in lieu of part of annual cash bonus

 

Number of Ordinary Shares held immediately following Admission

 

 

 

 

Percentage of the Company's enlarged share capital held immediately following Admission

Kevin Davidson

CEO

161,333

419,219

0.68%

Sean Buchan

COO1

158,400

158,400

0.26%

John Begley

PDMR

187,953

195,362

0.32%

Michael Diamond

PDMR

158,400

308,400

0.50%

Certain employees

-

410,667

410,667

0.66%

Total

 

1,076,753

 

 

1 On 24 August 2022, Sean Buchan was appointed as the Company's COO, a non-Board role. Previously, Steve Smith, the Company's CFO, had also been the COO

 

Total Voting Rights

Immediately following Admission, the Company will have 61,817,510 Ordinary Shares in issue, none of which will be held in treasury. Accordingly, shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Peter Searle, Non-Executive Chairman of the Company, commented:

"I am delighted that certain members of the team have chosen to take New Shares in lieu of part of their annual cash bonus thereby demonstrating their continued commitment to the Company's growth and increase in shareholder value."

 

 

For further Information, please contact:

Norman Broadbent plc       020 7484 0000

Peter Searle, Chairman

Kevin Davidson, CEO

Steve Smith, CFO

 

Shore Capital        020 7408 4090

Nominated Adviser and Broker

Tom Griffiths / Tom Knibbs (Corporate Advisory)

Henry Willcocks (Corporate Broking)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQFLFFLFLZFBX
Date   Source Headline
25th Apr 20247:00 amRNSQ1 2024 Trading Update
24th Apr 20247:00 amRNSSmall Cap Awards nomination
15th Apr 20243:18 pmRNSNotification of major holdings
8th Apr 202412:11 pmRNSIssue of Equity and Total Voting Rights
3rd Apr 20244:01 pmRNSNotification of major holdings
28th Mar 20247:00 amRNSPosting of ARA & Notice of AGM
27th Mar 20247:00 amRNSFinal Results
26th Mar 20244:07 pmRNSNotification of major holdings
20th Mar 20241:36 pmRNSNotice of Results & Investor Presentation
18th Mar 20244:33 pmRNSNotification of major holdings
18th Mar 20244:04 pmRNSNotification of major holdings
12th Mar 20243:33 pmRNSAIM Rule 17 Schedule Two (g) Update
22nd Jan 20245:32 pmRNSNotification of Major Holdings
16th Jan 20247:00 amRNSTrading Update
21st Nov 202310:06 amRNSNotification of Major Holdings
20th Nov 202310:45 amRNSDirector/PDMR shareholding
15th Nov 20239:54 amRNSNotification of Major Holdings
15th Nov 20239:43 amRNSNotification of Major Holdings
10th Nov 20237:00 amRNSDirector/PCA Dealing
9th Nov 20232:25 pmRNSDirector/PDMR Shareholding
2nd Nov 20238:43 amRNSConversion Of Outstanding Convertible Loan Notes
12th Oct 20237:00 amRNSQ3 2023 Trading Update
10th Oct 202311:03 amRNSNotification of Major Holdings
9th Oct 20237:00 amRNSSurrender and Granting of Options
28th Jul 20237:00 amRNSGrant of Options
24th Jul 20237:00 amRNSInterim Results
11th Jul 20237:00 amRNSH1 2023 Trading Update
30th Jun 20237:00 amRNSSAYE Option Plan & Director Holding
29th Jun 20234:28 pmRNSResult of AGM
5th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Jun 20237:00 amRNSDirectorate changes
31st May 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSQ1 2023 Trading Update
19th May 202312:55 pmRNSPartial Repayment of Convertible Loan Note
24th Jan 20237:00 amRNSTrading Update
10th Jan 20237:00 amRNSDirectorate Change
17th Nov 20224:42 pmRNSTR-1: Notification of major holdings
14th Nov 20227:00 amRNSIssue of Equity
1st Nov 20227:00 amRNSUpdate and Change of Board role
10th Oct 20225:30 pmRNSTR-1: Notification of major holdings
31st Aug 20227:00 amRNSDirector Share Purchase
23rd Aug 20227:00 amRNSDirectorate Change
16th Aug 20227:00 amRNSInterim Results
29th Jul 20227:00 amRNSChange of Adviser
20th Jul 20224:08 pmRNSDirector/PDMR Dealing
11th Jul 20227:00 amRNSTrading Update
29th Jun 20223:15 pmRNSDirector/PDMR Shareholding
23rd Jun 202212:14 pmRNSResult of AGM
7th Jun 20228:59 amRNSHolding(s) in Company
25th May 20227:00 amRNSFinal 2021 Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.